<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M811</article-id>
      <article-id pub-id-type="publisher-id">molbank-2013-M811</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ethyl 2-(3-Methyl-5-oxo-4,5-dihydro-3<italic>H</italic>-benzo[<italic>e</italic>][1,4]diazepin-2-ylamino)benzoate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Said</surname>
            <given-names>Naim H.</given-names>
          </name>
          <xref rid="af1-molbank-2013-M811" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2013-M811" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2013-M811" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Sghair</surname>
            <given-names>Ayat M.</given-names>
          </name>
          <xref rid="af1-molbank-2013-M811" ref-type="aff">1</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2013-M811"><label>1</label>Department of Chemistry, Jordan University of Science and Technology, Irbid 22110, Jordan</aff>
      <aff id="af2-molbank-2013-M811"><label>2</label>College of Applied Medical Sciences-Al Ahsa, King Saud bin Abdulaziz University for Health Sciences, Al-Ahsa 31982, Kingdom of Saudi Arabia</aff>
      <author-notes>
        <corresp id="c1-molbank-2013-M811"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>naim@just.edu.jo.</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>2013</volume>
      <issue>4</issue>
      <elocation-id>M811</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A simple route for synthesis of ethyl 2-(3-methyl-5-oxo-4,5-dihydro-3<italic>H</italic>-benzo[<italic>e</italic>][1,4]diazepin-2-ylamino)benzoate is developed. The present work involves condensation of 2-(2-nitrobenzamido)propanoic acid with ethyl anthranillate followed by the H<sub>2</sub>/Pd/C reduction to give the amino ester which upon heating in DMF in the presence of FeCl<sub>3</sub> affords the title compound. The structure of the title compound was established on the basis of <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and mass spectral data.</p>
      </abstract>
      <kwd-group>
        <kwd>benzo[<italic>e</italic>][1,4]diazepine</kwd>
        <kwd>ferric chloride</kwd>
        <kwd>cyclization</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>The growing importance of substituted [1,4]benzodiazepines in the field of medicinal chemistry as potential chemotherapeutic agents have incited the organic synthetic community to devise efficient methodologies to construct these bicyclic hetero-compounds [<xref ref-type="bibr" rid="B1-molbank-2013-M811">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2013-M811">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2013-M811">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2013-M811">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2013-M811">5</xref>].</p>
      <p>Little attention has been devoted to the structural perturbations caused by substitution at C-2 position in 1,4-diazepines possessing an imine bond (N1-C2) [<xref ref-type="bibr" rid="B6-molbank-2013-M811">6</xref>]. This fact, coupled with continuation of our work on the cyclization modes of tripeptide containing two units of anthranilic acid and an amino acid, prompted us to devise an efficient method of synthesis for benzo[<italic>e</italic>][1,4]diazepinone using transition metals [<xref ref-type="bibr" rid="B7-molbank-2013-M811">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2013-M811">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2013-M811">9</xref>]. The synthetic procedure described here can be protracted to prepare a wide range of derivatives for further biological evaluation.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>(<italic>S</italic>)-2-(2-Nitrobenzamido)propanoic acid <bold>1</bold> [<xref ref-type="bibr" rid="B10-molbank-2013-M811">10</xref>] was coupled with ethyl 2-aminobenzoate using a standard procedure to afford <bold>2</bold> in good yield (70%, <xref ref-type="scheme" rid="molbank-2013-M811-sch001">Scheme 1</xref>). The reduction of the nitro group was conducted under mild conditions (H<sub>2</sub>/Pd/(C)) to furnish the corresponding amine <bold>3</bold>. The <sup>1</sup>H-NMR spectrum of <bold>3</bold> indicated the presence of NH<sub>2</sub> group by displaying a broad D<sub>2</sub>O exchangeable signal at &#x3B4; 5.45. Furthermore, the methine proton was observed as doublet of quartet at &#x3B4; 4.73, the ethyl group protons were observed as triplet and quartet at &#x3B4; 1.31, 4.29, respectively. </p>
      <p>The synthesis of the title compound <bold>4</bold> was accomplished by heating amine <bold>3</bold> in DMF at 110 &#xB0;C in the presence of fused transition metal chlorides. Three transition metal chlorides (MgCl<sub>2</sub>, ZnCl<sub>2</sub> and FeCl<sub>3</sub>) were implemented. The cyclization of amine <bold>3</bold> was best achieved using fused FeCl<sub>3</sub> to afford the title benzodiazepinone compound in 75% yield.</p>
      <p>The <sup>1</sup>H-NMR spectrum of the title compound displayed the methine proton attached to the stereogenic center at &#x3B4; 4.23 as quartet. Moreover, and a doublet signal representing the methyl group next to stereogenic carbon was observed at 1.82 ppm. The <sup>13</sup>C-NMR spectrum displayed a signal at 21.9 ppm for the methyl carbon next to the stereogenic center. The mass spectrum of <bold>4</bold> showed the M<sup>+</sup> peak at <italic>m/z</italic> 337.9 attributed to the molecular formula C<sub>19</sub>N<sub>3</sub>O<sub>3</sub>H<sub>19</sub> (M+H<sup>+</sup>).</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <p>Amine <bold>3</bold> (400 mg, 1.13 mmol) was dissolved in DMF (30 mL) containing fused FeCl<sub>3</sub> (543.08 mg, 3.39 mmol). The resulting mixture was then heated with continuous stirring in oil bath for 24 h at 110 &#xB0;C. The reaction mixture was cooled to room temperature, diluted with water (100 mL) and then extraction with 40% EtoAc/hexane (2 &#xD7; 100 mL). The combined organic layer was dried over MgSO<sub>4</sub>, filtered and concentrated. The residue was purified by column chromatography on silica gel eluting with 40% ethyl acetate in hexane to give the title compound <bold>4</bold> (285 mg, 75% yield) as a pale yellow oil. <sup>1</sup>H-NMR (400 MHz, CDCl<sub>3</sub>): &#x3B4; 1.28 (t, <italic>J</italic> = 7.1 Hz, 3H), 1.82 (d, <italic>J</italic> = 7.2 Hz, 3H) 4.23 (q, <italic>J</italic> = 7.0 Hz, 1H) 5.65 (q, <italic>J</italic> = 7.2 Hz, 2H) 7.05 (t, <italic>J</italic> = 4 Hz, 1H), 7.45 (m, 2H), 7.70 (m, 2H), 7.95 d, <italic>J</italic> = 5 Hz, 1H), 8.19 (s, 1H), 8.45 (m, 2H), 8.60 (d, <italic>J</italic> = 3 Hz, 1H), 11.5 (s, 1H); <sup>13</sup>C-NMR (100 MHz, CDCl<sub>3</sub>): &#x3B4; 19.0, 21.9, 34.8, 58.7, 120.7, 125.3, 128.0, 131.9, 132.1, 132.4, 135.7, 139.3, 139.4, 145.6, 149.0, 152.6, 165.7, 173.0; ESI-MS <italic>m/z</italic> 337.9 (M<sup>+</sup>); Anal Calcd. for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>: C, 67.64; H, 5.68; N, 12.46; O, 14.23. Found: C, 67.69; H, 5.63; N, 12.52.</p>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2013-M811">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2013-M811-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M811-s001.pdf">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2013-M811-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M811-s002-mod.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2013-M811-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M811-s002.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by the Deanship of Research at Jordan University of Science and Technology.</p>
    </ack>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2013-M811">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Neumeyer</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Baldessarini</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Xuechu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ao</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders</article-title>
          <source>Chem. Rev.</source>
          <year>2013</year>
          <volume>113</volume>
          <fpage>123</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1021/cr300113a</pub-id>
          <pub-id pub-id-type="pmid">23464812</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2013-M811">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verdi&#xE9;</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Subra</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Feliu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Berg&#xE9;</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Garcin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Martinez.</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>on-Line synthesis of pseudopeptide library incorporating a benzodiazepinone turn mimic:&#x2009; Biological Evaluation on MC1 Receptors</article-title>
          <source>J. Comb. Chem.</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>254</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1021/cc060054q</pub-id>
          <pub-id pub-id-type="pmid">17348731</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2013-M811">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Khoury</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chanas</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Domling</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Multicomponenet synthesis of diverse 1,4-benzodiazepine scaffolds</article-title>
          <source>Org. Lett.</source>
          <year>2012</year>
          <volume>14</volume>
          <fpage>5916</fpage>
          <lpage>5919</lpage>
          <pub-id pub-id-type="doi">10.1021/ol302837h</pub-id>
          <pub-id pub-id-type="pmid">23157402</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2013-M811">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hadjipavlou</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Hansch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Quantitative structure-activity relationships of benzodiazepines</article-title>
          <source>Chem. Rev.</source>
          <year>1994</year>
          <volume>94</volume>
          <fpage>1483</fpage>
          <lpage>1505</lpage>
          <pub-id pub-id-type="doi">10.1021/cr00030a002</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2013-M811">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Welsch</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Stockwell</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>Privileged scaffolds for library design and drug discovery</article-title>
          <source>Curr. Opin. Chem. Biol.</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>347</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cbpa.2010.02.018</pub-id>
          <pub-id pub-id-type="pmid">20303320</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2013-M811">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sardina</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Rapoport</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Enantionspecific synthesis of heterocycles from &#x3B1;-amino acids</article-title>
          <source>Chem. Rev.</source>
          <year>1996</year>
          <volume>96</volume>
          <fpage>1825</fpage>
          <lpage>1872</lpage>
          <pub-id pub-id-type="doi">10.1021/cr9300348</pub-id>
          <pub-id pub-id-type="pmid">11848813</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2013-M811">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Effective formal synthesis of benzomalvin A</article-title>
          <source>Monatsh. Chem.</source>
          <year>2010</year>
          <volume>141</volume>
          <fpage>1249</fpage>
          <lpage>1251</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-010-0387-0</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2013-M811">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Shawakfeh</surname>
              <given-names>K.Q.</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Tayyem</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>A facile synthesis of quinazolino[1,4]benzodiazepine alkaloids via reductive <italic>N</italic>-heterocyclization of <italic>N</italic>-(2-nitrobenzoyl)amides: Total synthesis of asperlicin C, circumdatin H, and analogues</article-title>
          <source>ARKIVOC</source>
          <year>2010</year>
          <volume>ix</volume>
          <fpage>282</fpage>
          <lpage>292</lpage>
        </citation>
      </ref>
      <ref id="B9-molbank-2013-M811">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taher</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ishtaiwi</surname>
              <given-names>Z.N.</given-names>
            </name>
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Efficient protocol to quinazolino[3,2-<italic>d</italic>][1,4]benzodiazepine-6,9-dione via Staudinger-aza-Wittig cyclizationapplication to synthesis of Asperlicin D</article-title>
          <source>ARKIVOC</source>
          <year>2008</year>
          <volume>xvi</volume>
          <fpage>154</fpage>
          <lpage>164</lpage>
        </citation>
      </ref>
      <ref id="B10-molbank-2013-M811">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffmann</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jagnicinski</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>The formation of lactams of <italic>N</italic>-(2-amino)benzoylamino acids</article-title>
          <source>J. Heterocyclic. Chem.</source>
          <year>1966</year>
          <volume>3</volume>
          <fpage>348</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570030323</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2013-M811-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2013-M811-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of (<italic>S</italic>)-ethyl 2-(3-methyl-5-oxo-4,5-dihydro-3<italic>H</italic>-benzo[<italic>e</italic>][1,4]diazepin-2-ylamino)benzoate (<bold>4</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M811-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
